Back
Design Therapeutics 10K Form
Sell
25
DSGN
Design Therapeutics
Last Price:
$3.99
Seasonality Move:
-7.13%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive DSGN News And Ratings
See the #1 stock for the next 7 days that we like better than DSGN
DSGN Financial Statistics
Sales & Book Value
| Annual Sales: | $230K |
|---|---|
| Cash Flow: | $-16.9M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $4.01 |
| Price / Book: | 1 |
Profitability
| EPS (TTM): | -0.99000 |
|---|---|
| Net Income (TTM): | $-56.2M |
| Gross Margin: | -- |
| Return on Equity: | 0% |
| Return on Assets: | 0% |
Design Therapeutics Earnings Forecast
Key Design Therapeutics Financial Ratios
-
Per Share Earnings over the last 6 years have been positive in 1 years.
Design Therapeutics Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | DSGN |
| Website: | designtx.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 0 |
| Quick Ratio: | 0 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
DSGN Technical Analysis vs Fundamental Analysis
Sell
25
Design Therapeutics (DSGN)
is a Sell
Is Design Therapeutics a Buy or a Sell?
-
Design Therapeutics stock is rated a SellThe current Design Therapeutics [DSGN] share price is $4.01. The Score for DSGN is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.